Erlotinib is an oral targeted therapy used to treat non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, preventing cancer cell growth. It’s effective in patients with EGFR mutations, improving survival and disease progression.
| Pack Size | 1*30 |
|---|---|
| Form | Tablet |
| Manufacturer | Natco |
| Storage Conditions | Ambient Temperature |
| Shelf Life | 2 Years |
Trade Marks displayed in compliance with provisions of: provisions Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”
GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of PANTIN-D CAP – Domperidone+ Pantoprazole which is also known as PANTIN and Manufactured by Hetro pharmaceutical. It is available in strength of (30mg) + (40mg) per ml.
PANTIN-D CAP – Domperidone+ Pantoprazole is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.
Trade Marks displayed in compliance with provisions of: Trademark Act, 1999 u/s 30 and 30 (1) of “Fair use”
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required in the act.
